tiprankstipranks

Illumina reports Q1 non-GAAP EPS 8c, consensus 2c

Reports Q1 revenue $1.09B, consensus $1.07B. "The year is off to a solid start, led by NovaSeq X outperforming expectations in both customer demand and manufacturing supply," said Francis deSouza, CEO. "We shipped 67 NovaSeq X instruments in the first quarter, exceeding our plan. Demand remains strong, with our quarter-end NovaSeq X order book standing at over 200 instruments. We continue to work closely with our customers and partners to help them manage the challenging macroeconomic environment and to deliver on our 2023 goals. Our commitment to higher margins will set Illumina on the best path to deliver long-term sustainable success for our shareholders."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on ILMN:

Disclaimer & DisclosureReport an Issue